Johnson & Johnson received FDA approval for a 2.25-millimeter version of its Cypher drug-eluting stent, designed to treat smaller blood vessels. The agency granted approval after a study showed that the device was more effective than bare-metal stents in keeping small blood vessels from reclogging.

Full Story:

Related Summaries